Advertisement
Screener

CRESCENT BIOPHARMA, INC. (CBIO) ROA

CRESCENT BIOPHARMA, INC. (CBIO) ROA

  • 2026-06-30: ROA -52.54%.
  • 2026-03-31: ROA -46.69%.
  • 2025-12-31: ROA -35.31%.
  • 2025-09-30: ROA -49.73%.

Complete source-backed roa history.

Available history
2013-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-52.54%
2026-03-31-46.69%
2025-12-31-35.31%
2025-09-30-49.73%
2025-06-30-34.29%
2025-03-31-705.76%
2024-12-31-106.35%
2024-09-30-253.12%
2024-06-30-160.18%
2024-03-31-108.98%
2023-12-31-81.43%
2023-09-30-71.55%
2023-06-30-60.47%
2023-03-31-61.51%
2022-12-31-90.11%
2022-09-30-96.26%
2022-06-30-96.36%
2022-03-31-78.32%
2021-12-31-67.23%
2021-09-30-57.04%
2021-06-30-46.60%
2021-03-31-41.76%
2020-12-31-35.73%
2020-09-30-33.37%
2020-06-30-31.40%
2020-03-31-31.75%
2019-12-31-34.47%
2019-09-30-31.63%
2019-06-30-28.80%
2019-03-31-24.87%
2018-12-31-22.36%
2018-09-30-19.27%
2018-06-30-16.87%
2018-03-31-14.80%
2017-12-31-25.88%
2017-09-30-27.93%
2017-06-30-26.52%
2017-03-31-86.58%
2016-12-31-75.04%
2016-09-30-67.41%
2016-06-30-56.80%
2016-03-31-32.47%
2015-12-31-26.35%
2015-09-30-20.24%
2015-06-30-17.30%
2015-03-31-27.09%
2014-12-31-19.42%
2014-09-30-12.17%
2014-06-30-6.93%
2014-03-31-27.84%
2013-12-31-200.73%

Annual ROA

DateROA
2025-12-31-64.06%
2024-12-31-106.35%
2023-12-31-81.43%
2022-12-31-90.11%
2021-12-31-67.23%
2020-12-31-35.73%
2019-12-31-34.47%
2018-12-31-22.47%
2017-12-31-25.88%
2016-12-31-75.04%
2015-12-31-26.35%
2014-12-31-19.42%
2013-12-31-200.73%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
Evolus, Inc. (EOLS)United States$0.519B-13.32
ARVINAS, INC. (ARVN)United States$0.510B58.38
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Altimmune, Inc. (ALT)United States$0.593B-6.43
Monopar Therapeutics (MNPR)United States$0.598B-34.82